Empowered Funds’s NeoGenomics NEO Stock Holding History

Empowered Funds’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-43,690	Closed	-$1.35M	–	138
2020 Q2	$1.35M	Buy	+43,690	New	+$1.21M	0.52%	71
2019 Q4	–	Sell	-48,714	Closed	-$931K	–	131
2019 Q3	$931K	Sell	48,714 -4,269	-8%	-$100K	0.41%	90
2019 Q2	$1.16M	Sell	52,983 -24,322	-31%	-$534K	0.49%	73
2019 Q1	$1.58M	Buy	+77,305	New	+$1.34M	0.57%	50

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Empowered Funds's NEO Position: Q3 2020 in Review

Empowered Funds sold out of NeoGenomics (NEO) in Q3 2020, closing a stake of 43,690 shares — an estimated $1.35M sold.

Empowered Funds first reported a position in NEO in Q1 2019 and held it in 4 quarters. The position peaked at $1.58M in Q1 2019. 294 funds tracked by Wall St. Rank hold NEO as of Q3 2020.

Empowered Funds reported no remaining NeoGenomics position as of Q3 2020 after selling out during the quarter.
Empowered Funds sold 43,690 NeoGenomics shares in Q3 2020, an estimated $1.35M.
Empowered Funds first reported a position in NeoGenomics in Q1 2019 and held it in 4 quarters.
Empowered Funds's NeoGenomics position peaked at $1.58M in Q1 2019.
294 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2020.

Based on Empowered Funds's 13F filing for Q3 2020, filed 26 Oct 2020.